Related Experiment Video
Updated: Jul 14, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Cardiac cell therapy and arrhythmias
Shunichiro Miyoshi1, Yukinori Ikegami, Yuji Itabashi
1Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 186-8582, Japan. smiyoshi@cpnet.med.keio.ac.jp
Insights
Cardiac stem cell therapy shows promise for heart failure but may cause arrhythmias. Understanding stem cell electrophysiology is crucial for preventing adverse effects and developing safer treatments.
Area of Science:
- Cardiology
- Regenerative Medicine
- Electrophysiology
Background:
- Cardiac stem cell therapy offers potential for severe heart failure treatment.
- Various stem cell types are explored, including embryonic stem cells, myoblasts, and mesenchymal stem cells.
- Arrhythmogenic adverse effects are a concern with current stem cell therapies.
Purpose of the Study:
- To review recent publications on the electrophysiological properties of stem cell-derived cardiomyocytes.
- To understand the mechanisms underlying stem cell-induced arrhythmias.
- To provide a new perspective on cardiac stem cell therapy for arrhythmias.
Main Methods:
- Systematic review of existing literature on stem cell electrophysiology.
- Analysis of experimental and clinical data on stem cell therapy outcomes.
- Exploration of mechanisms linking stem cell properties to cardiac arrhythmias.
Main Results:
- Stem cell-derived cardiomyocytes possess distinct electrophysiological characteristics.
- Specific properties of stem cells may contribute to arrhythmogenesis.
- Knowledge gaps exist regarding the in situ arrhythmogenic potential of these cells.
Conclusions:
- Understanding stem cell electrophysiology is vital for mitigating arrhythmia risks.
- Further research is needed to ensure the safety and efficacy of cardiac stem cell therapy.
- Developing strategies to control stem cell electrophysiology could enhance therapeutic outcomes.
Abstract:
Cardiac stem cell based therapy is a promising therapy for patients with severe heart failure. Many types of stem cells, such as embryonic stem cells, myoblasts, marrow-derived mesenchymal stem cells, circulating endothelial progenitor cells, and cardiac precursor cells etc, are known as cellular sources for cardiac stem cell therapy. Both in the clinical and experimental setting, stem cells are reported, and supposed, to cause some arrhythmogenic adverse effects. In order to overcome these serious adverse effects, it is necessary to know the electrophysiological properties of stem cell-derived cardiomyocytes, and have a profound insight into the mechanisms of arrhythmia to know whether such arrhythmogenic properties of the cells can cause serious arrhythmia in situ. In the present study, recent publications that focus on the electrophysiological aspect of stem cell based therapy are reviewed and, furthermore, a new perspective on cardiac stem cell therapy of arrhythmias is given.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

